Related Experiment Video

Updated: Jun 25, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

[Pediatrics]

S Fanconi1, E Giannoni, M Roth-Kleiner

  • 1Service de pédiatrie, CHUV, Lausanne. sergio.fanconi@chuv.ch

Revue Medicale Suisse
|February 17, 2009
PubMed

Insights

This research reviews pediatric advances, questioning pure oxygen for newborn resuscitation and highlighting bullying detection in adolescents. It also details respiratory monitoring for Duchenne muscular dystrophy patients to improve quality of life.

Area of Science:

  • Pediatrics
  • Neonatology
  • Adolescent Medicine
  • Neuromuscular Disorders

Context:

  • Recent studies challenge traditional neonatal resuscitation protocols.
  • Bullying is a significant issue affecting vulnerable children, requiring medical attention.
  • Effective management of Duchenne muscular dystrophy is crucial for patient well-being.

Purpose:

  • To present recent advancements in pediatrics across three key areas.
  • To inform clinical practice regarding neonatal resuscitation, bullying intervention, and Duchenne muscular dystrophy care.
  • To emphasize the importance of updated guidelines and proactive management strategies.

Summary:

  • Evidence suggests lower oxygen concentrations or air may be preferable for neonatal resuscitation.
  • Physicians play a vital role in identifying and protecting children who are victims of bullying.
  • Respiratory surveillance and timely initiation of non-invasive ventilation are essential for Duchenne muscular dystrophy patients.

Impact:

  • Potential to refine neonatal resuscitation guidelines, improving outcomes for newborns.
  • Empowers healthcare professionals to address and mitigate the effects of bullying on child health.
  • Aims to enhance the quality of life and longevity for individuals with Duchenne muscular dystrophy through optimized respiratory support.

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...